Purpose of these studies

The purpose of these studies is to evaluate the effectiveness and safety of an investigational medicine, REGN-COV2, that may treat or prevent COVID-19.

Who may participate in this study?

You may qualify for these research studies if the following applies to you:

• You are at least 18 years old  
• You have been diagnosed with/suspect you have Coronavirus (COVID-19/ SARS-CoV-2)  

OR

• You are at least 18 years old  
• Your household member has been recently (within the last 3 days) diagnosed with/ suspect they have Coronavirus (COVID-19/ SARS-CoV-2)

There are other eligibility requirements. A final decision on whether these research studies might be suitable for you will be made after you complete the online and phone questionnaire and speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in these research studies.

Reimbursement

Adults with confirmed COVID infection may receive reimbursement up to $3650 related to study participation while adults who currently reside with someone who has a confirmed COVID diagnosis may receive reimbursement up to $4,875 related to study participation.

The level of reimbursement may vary between sites and based on the study you qualify for, details will be provided by the study doctor.

Sponsor

These studies are sponsored by Regeneron Pharmaceuticals, Inc. Regeneron is applying its 30 years of scientific and technology expertise to advance research on the COVID-19 pandemic through the company’s REGN-COV2 clinical trials, which began in mid-June.